From: Contrast media extravasation injury: a prospective observational cohort study
Variable | Odds ratio (95% confidence interval) | P-value |
---|---|---|
Univariate analysis | ||
Sex (reference: female) | 0.649 (0.242‒1.740) | 0.390 |
Age (reference: ≤ 50 years) | ||
50 < age ≤ 60 | 3.467 (0.705‒17.057) | 0.126 |
60 < age < 70 | 0.394 (0.035‒4.465) | 0.452 |
Age ≥ 70 | 6.500 (1.264‒33.416) | 0.025 |
BMI ≥ 25 | 1.232 (0.418–3.629) | 0.705 |
Malignant tumor | 4.447 (1.526‒12.960) | 0.006 |
Diabetes | 2.621 (0.919‒7.478) | 0.072 |
Venous thrombosis | 1.390 (0.295‒6.557) | 0.678 |
Hypoalbuminemia | 0.763 (0.167‒3.494) | 0.727 |
Pulmonary infection | 2.095 (0.770‒5.701) | 0.148 |
Multi-site angiography | 0.618 (0.212‒1.801) | 0.378 |
Injection rate ≥ 3 mL/s | 0.472 (0.171‒1.305) | 0.148 |
Type of contrast media (reference: Iodixanol) | ||
Iohexol | 8.296 (2.054–33.507) | 0.013 |
Ioversol | 1.750 (0.279–10.963) | 0.550 |
Others | 2.222 (0.512–9.647) | 0.286 |
Large volume (> 50 mL) extravasation | 3.735 (1.383‒10.090) | 0.009 |
Insertion left side | 4.654 (1.715‒12.630) | 0.003 |
Injection site (reference: Forearm and elbow fossa) | ||
Back of the hand | 11.156 (3.506‒35.500) | < 0.001 |
Neck | 0.000 (0.000‒0.000) | 0.999 |